Anomia Treatment Predictors
NCT06619756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2025-11-12
Summary
The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Researchers will compare Phonomotor Treatment and Phonological Components Analysis to see which treatment is more beneficial, and for whom. Participants will engage in both treatments over several months.
Conditions
- Aphasia
- Anomia (Word-Finding Impairment)
Interventions
- BEHAVIORAL
-
Phonomotor Treatment (PMT)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
- BEHAVIORAL
-
Phonological Components Analysis (PCA)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
Sponsors & Collaborators
-
State University of New York at Buffalo
lead OTHER
Principal Investigators
-
Nichol Castro, PhD · SUNY at Buffalo
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-18
- Primary Completion
- 2025-10-01
- Completion
- 2025-10-01
Countries
- United States
Study Locations
More Related Trials
-
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
NCT06223360 ·Status: RECRUITING ·Phase: PHASE2
-
Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial
NCT04489017 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
NCT02211560 ·Status: TERMINATED ·Phase: NA
-
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
NCT04491006 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494 ·Status: RECRUITING ·Phase: PHASE2
-
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
NCT02187276 ·Status: COMPLETED
-
Propranolol in Primary Progressive Aphasia
NCT06066710 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
NCT04191486 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
NCT02615002 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
NCT04726527 ·Status: COMPLETED
-
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
NCT04951284 ·Status: TERMINATED
-
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
NCT02500784 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)
NCT03088956 ·Status: COMPLETED
-
Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease
NCT07178678 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
NCT06546995 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Dopaminergic Therapy for Frontotemporal Dementia Patients
NCT04937452 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
NCT00120874 ·Status: COMPLETED ·Phase: PHASE4
-
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension
NCT04937959 ·Status: UNKNOWN
-
Efficacy and Safety of MMFS in Early AD
NCT03531684 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
NCT00842673 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4